RA
AMED

Rise Advisors’s Amedisys AMED Stock Holding History

Rise Advisors’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-16
Closed -$1.57K – 1527
2025
Q2 		$1.57K Buy
+16
New +$1.51K ﹤0.01% 1219
2025
Q1 		– Sell
-125
Closed -$11.3K – 1503
2024
Q4 		$11.3K Hold
125
– – 0.01% 946
2024
Q3 		$12.1K Hold
125
– – 0.01% 961
2024
Q2 		$11.5K Hold
125
– – 0.01% 962
2024
Q1 		$11.5K Buy
+125
New +$11.7K 0.01% 1019

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Rise Advisors's AMED Position: Q3 2025 in Review

Rise Advisors sold out of Amedisys (AMED) in Q3 2025, closing a stake of 16 shares — an estimated $1.57K sold.

Rise Advisors first reported a position in AMED in Q1 2024 and held it in 5 quarters. The position peaked at $12.1K in Q3 2024. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Rise Advisors reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Rise Advisors sold 16 Amedisys shares in Q3 2025, an estimated $1.57K.
  • Rise Advisors first reported a position in Amedisys in Q1 2024 and held it in 5 quarters.
  • Rise Advisors's Amedisys position peaked at $12.1K in Q3 2024.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Rise Advisors's 13F filing for Q3 2025, filed 8 Oct 2025.